New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
07:27 EDTAMAGAMAG Pharmaceuticals upgraded to Outperform from Market Perform at Leerink
Leerink upgraded AMAG Pharmaceuticals on expectations Feraheme sales estimates are now achievable and label expansion can drive upside. The firm raised its price target for shares to $19 from $17.
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
20:03 EDTAMAGAMAG Pharmaceuticals 3.15M share Secondary priced at $63.75
Jefferies and Barclays acted as joint book running managers for the offering.
08:29 EDTAMAGAMAG says 'additional insight' gained into FTC investigation
Subscribe for More Information
08:26 EDTAMAGAMAG capital raise removes overhang, says Leerink
Subscribe for More Information
July 29, 2015
17:15 EDTAMAGAMAG Pharmaceuticals announces proposed offering of $200M of common stock
Subscribe for More Information
July 23, 2015
09:13 EDTAMAGOn The Fly: Pre-market Movers
Subscribe for More Information
07:25 EDTAMAGAMAG affirms FY15 revenue view $395M-$430M, consensus $465.45M
Raises FY15 adjusted EBITDA guidance view to $210M-$225M from $200M-$220M.
07:23 EDTAMAGAMAG reports Q2 adjusted EPS $1.12, one estimate $1.13
Subscribe for More Information
July 22, 2015
16:10 EDTAMAGAMAG acquires option for rights to Velo Bio's digoxin immune fab
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use